Samsung Biologics dividend history
This page focuses on the dividend history of Samsung Biologics (207940) on KRX: ex-dividend dates, pay dates, amounts and yield, using delayed sample data.
Price chart
Key statistics
Related
About Samsung Biologics
AI-assisted summarySamsung Biologics (207940) is a company listed on KRX in the Health Care sector. This page summarises its share price, key statistics, dividends and fundamentals using delayed and sample data — figures may differ from official sources. As of Jun 26, 2026, 207940 last traded at ₩980,000 (+1.55%) in this delayed sample dataset.
Dividend history
Samsung Biologics does not currently pay a regular dividend.
Financials
Annual figures, last 5 fiscal years.
| Date | Revenue | Net income | EPS (TTM) | P/E (TTM) |
|---|---|---|---|---|
| FY2024 | ₩46.05T | ₩4.64T | ₩10,554 | 76.2× |
| FY2023 | ₩42.01T | ₩8.49T | ₩12,046 | 80.5× |
| FY2022 | ₩34.75T | ₩6.67T | ₩13,387 | 76.4× |
| FY2021 | ₩28.61T | ₩2.71T | ₩14,633 | 68.8× |
| FY2020 | ₩24.84T | ₩2T | ₩15,729 | 52.7× |
Stock splits
No stock splits on record for Samsung Biologics.
Analyst forecast
Aggregated analyst estimates (sample)
Related
Frequently asked questions
What is the current Samsung Biologics share price?
Samsung Biologics (207940) last traded at ₩980,000, as of Jun 26, 2026. Prices on bourva are delayed and shown for reference only.
Does Samsung Biologics pay a dividend?
Samsung Biologics does not currently pay a regular dividend.
What is Samsung Biologics's market capitalisation?
Samsung Biologics has an approximate market capitalisation of ₩69.58T.
What is Samsung Biologics's P/E ratio?
Samsung Biologics trades at a trailing P/E ratio of about 65.0.